United States Antimony (UAMY) director discloses RSU and stock option awards

Rhea-AI Filing Summary

United States Antimony Corp director Jon R. Marinelli reported new equity-based awards tied to his service with the company. He was granted derivative rights over 24,509 shares of common stock through a time-based restricted stock unit award under the Amended & Restated 2023 Equity Incentive Plan. One-third, or 8,170 shares, will vest on December 4, 2026, with additional one‑third portions vesting on December 4, 2027 and December 4, 2028, if he continues in service.

Marinelli was also granted stock options covering 15,182 shares of common stock at an exercise price of $6.12 per share. These options vest in three equal installments of 5,061 shares on December 4, 2026, December 4, 2027, and December 4, 2028, contingent on his continued service through each vesting date.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Marinelli Jon R

(Last) (First) (Middle)

4438 W LOVERS LANE, UNIT 100

(Street)

DALLAS TX 75209

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
11/24/2025

3. Issuer Name and Ticker or Trading Symbol
UNITED STATES ANTIMONY CORP [ UAMY ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock	(1)	(1)	Common Stock	24,509(1)	$0	D
Stock Options	(2)	12/04/2035	Common Stock	15,182(2)	$6.12	D

Explanation of Responses:

1. Represents shares of Common Stock underlying a time-based vesting restricted stock unit ("RSU") award granted on December 4, 2025 under the Issuer's Amended & Restated 2023 Equity Incentive Plan. One-third, or 8,170 shares of the 24,509 total number of shares, of the RSU award will vest on December 4, 2026 and an additional one-third of the total number of shares will vest on December 4, 2027 and December 4, 2028 subject to the Reporting Person's continued service through each vesting date.

2. Represents shares of Common Stock underlying a time-based vesting stock option award granted on December 4, 2025 under the Issuer's Amended & Restated 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 5,061 shares of the 15,182 total number of shares on December 4, 2026 and an additional one-third of the total number of shares will vest on December 4, 2027 and December 4, 2028, subject to the Reporting Person's continued service through any vesting date.

	/s/ Jon R Marinelli	01/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider equity awards were reported for UAMY director Jon R. Marinelli?

Jon R. Marinelli reported two equity awards in United States Antimony Corp common stock: a time-based restricted stock unit award over 24,509 shares and a time-based stock option award over 15,182 shares.

How do the UAMY restricted stock units for Jon R. Marinelli vest?

The restricted stock unit award for 24,509 shares vests in three equal parts. 8,170 shares vest on December 4, 2026, and additional one‑third portions vest on December 4, 2027 and December 4, 2028, subject to continued service.

What are the key terms of Jon R. Marinelli’s UAMY stock options?

Marinelli received stock options on 15,182 shares of common stock with an exercise price of $6.12 per share. The options also vest in three equal installments of 5,061 shares on December 4, 2026, December 4, 2027, and December 4, 2028, if he remains in service.

Under which plan were Jon R. Marinelli’s UAMY equity awards granted?

Both the restricted stock units and the stock options were granted under United States Antimony Corp’s Amended & Restated 2023 Equity Incentive Plan.

What is Jon R. Marinelli’s relationship to United States Antimony Corp (UAMY)?

Jon R. Marinelli is listed as a director of United States Antimony Corp in the filing.

What is the event date associated with Jon R. Marinelli’s UAMY insider filing?

The date of the event requiring the statement is reported as November 24, 2025.